These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38861912)

  • 1. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response.
    Xiao MY; Pei WJ; Li S; Li FF; Xie P; Luo HT; Hyun Yoo H; Piao XL
    Bioorg Chem; 2024 Sep; 150():107539. PubMed ID: 38861912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gypenosides suppress hepatocellular carcinoma cells by blocking cholesterol biosynthesis through inhibition of MVA pathway enzyme HMGCS1.
    Xiao MY; Li FF; Xie P; Qi YS; Xie JB; Pei WJ; Luo HT; Guo M; Gu YL; Piao XL
    Chem Biol Interact; 2023 Sep; 383():110674. PubMed ID: 37604220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo.
    Yu XQ; Yan QL; Shen S; Cheng ZY; Huang XX; Yao GD; Song SJ
    Bioorg Chem; 2022 Feb; 119():105509. PubMed ID: 34844768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
    Li P; Liu Y; He Q
    Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
    Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
    Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
    Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo.
    Huang NC; Huang RL; Huang XF; Chang KF; Lee CJ; Hsiao CY; Lee SC; Tsai NM
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
    Yin Y; Guo J; Teng F; Yu L; Jiang Y; Xie K; Jiang M; Fang J
    Drug Des Devel Ther; 2019; 13():4173-4184. PubMed ID: 31849449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of
    Liang Y; Xie Y; Liu X; Yu L; Yan H; Shang Z; Wu Y; Cai X; Shi W; Du J; Yang Z
    Drug Des Devel Ther; 2024; 18():2169-2187. PubMed ID: 38882048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antitumor Effects of Britanin on Hepatocellular Carcinoma Cells and its Real-Time Evaluation by In Vivo Bioluminescence Imaging.
    Li H; Du G; Yang L; Pang L; Zhan Y
    Anticancer Agents Med Chem; 2020; 20(9):1147-1156. PubMed ID: 32106805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.
    Wu J; Guo L; Qiu X; Ren Y; Li F; Cui W; Song S
    Br J Cancer; 2020 Nov; 123(11):1673-1685. PubMed ID: 32958824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00618 facilitates growth and metastasis of hepatocellular carcinoma via elevating cholesterol synthesis by promoting NSUN2-mediated SREBP2 m5C modification.
    Li R; Li S; Shen L; Li J; Zhang D; Yu J; Huang L; Liu N; Lu H; Xu M
    Ecotoxicol Environ Saf; 2024 Oct; 285():117064. PubMed ID: 39299205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
    Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
    Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The petroleum ether extracts of Chloranthus fortunei(A. Gray) Solms-Laub.with bioactivities: A rising source in HCC drug treatment.
    Gong X; Zhou Y; Wu P; He L; Ou C; Xiao X; Hou X; Shen Y; Li M; Tan Z; Xia X; Wang S
    J Ethnopharmacol; 2024 Oct; 333():118414. PubMed ID: 38830451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Induces LCAT to Maintain Cholesterol Homeostasis and Suppress Hepatocellular Carcinoma Development.
    He W; Wang M; Zhang X; Wang Y; Zhao D; Li W; Lei F; Peng M; Zhang Z; Yuan Y; Huang Z
    Cancer Res; 2024 Aug; 84(15):2417-2431. PubMed ID: 38718297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
    Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
    Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Huang XF; Sheu GT; Chang KF; Huang YC; Hung PH; Tsai NM
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma.
    Mok EHK; Leung CON; Zhou L; Lei MML; Leung HW; Tong M; Wong TL; Lau EYT; Ng IOL; Ding J; Yun JP; Yu J; Zhu HL; Lin CH; Lindholm D; Leung KS; Cybulski JD; Baker DM; Ma S; Lee TKW
    Cancer Res; 2022 Sep; 82(17):3102-3115. PubMed ID: 35767704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.